Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Intrapartum Papaverine 80 mg on Perineal Trauma Among Primiparous Women: a Prospective Randomized Double-blind Study.

NCT07641543 is registered in ClinicalTrials.gov with Dr Raneen Abu Shqara as lead sponsor.

NCT NCT07641543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07641543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Intrapartum Papaverine 80 mg on Perineal Trauma Among Primiparous Women: a Prospective Randomized Double-blind Study.
Lead sponsor
Dr Raneen Abu Shqara
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 3, 2026
Completion date
June 3, 2027
Enrollment
412 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obstetric anal sphincter injury, perineal trauma